Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.37
Delayed Data
As of Aug 15
 0.00 / 0.00%
Today’s Change
3.75
Today|||52-Week Range
9.25
-30.96%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close4.37
Today’s openn.a.
Day’s range-- - --
Volume600
Average volume (3 months)1,424,812
Market cap$351.5M
Dividend yield--
Data as of 08/15/2017

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+2.50%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book204.30

Competitors

 Today’s
change
Today’s
% change
NSTGNanoString Technolog...0.000.00%
MRSNMersana Therapeutics...+0.08+0.51%
SELBSelecta Biosciences ...0.000.00%
EDGEEdge Therapeutics In...0.000.00%
Data as of 9:36am ET, 08/16/2017

Financials

Last reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts